Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
34
pubmed:dateCreated
1996-10-16
pubmed:abstractText
Human alpha-1,3-fucosyltransferase catalyzes the transfer of the L-fucose moiety from guanosine diphosphate-beta-L-fucose (GDP-Fuc) to acceptor sugars to form biologically important fucoglycoconjugates, including sialyl Lewis x (SLex). Evidence for a general base mechanism is supported by a pH-rate profile that revealed a catalytic residue with a pKa of 4.1. The characterized solvent kinetic isotope effect (Dv = 2.9, Dv/k = 2.1) in a proton inventory study indicates that only one-proton transfer is involved in the catalytic step leading to the formation of the transition state. Evidence for Mn2+ as an electrophilic catalyst was supported by the observation that the nonenzymatic transfer of L-fucose from GDP-Fuc to the hydroxyl group of water in the presence of 10 mM MnCl2 at 20 degrees C was accelerated from K(obs)= 3.5 x 10(-6) to 3.8 x 10(-5) min-1. Using the GDP-Fuc hydrolysis as the nonenzymatic rate, the enzymatic proficiency of FucT V, (Kcat/Ki,GDP-fuc. K(m),1.acNAc)/K(non), was estimated to be 1.2 x 10(10) M-1 with a transition-state affinity of 8.6 x 10(-11) M. The Km for Mn2+ was determined to be 6.1 mM, and alternative divalent metal cofactors were identified as Ca2+, Co2+, and Mg2+. Detailed kinetic characterization of the acceptor sugar specificity indicated that incorporation of hydrophobic functionality [e.g. -O-(CH2)5CO2CH3] to the reducing end of the acceptor sugar substantially decreased the K(m),acceptor by over 100-fold. The role of the nucleotide was investigated by studying the inhibition of nucleotides, including the guanosine series. The inhibitory potency trend (GTP approximately GDP > GMP > > guanosine) is consistent with bidentate chelation of Mn2+ by GDP-Fuc. The role of charge and distance in the synergistic inhibitory effect by the combination of GDP, an aza sugar, and the acceptor sugar was probed. A mechanism for fucosyl transfer incorporating these findings is proposed and discussed.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/1-Deoxynojirimycin, http://linkedlifedata.com/resource/pubmed/chemical/Amino Sugars, http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD15, http://linkedlifedata.com/resource/pubmed/chemical/Cations, Divalent, http://linkedlifedata.com/resource/pubmed/chemical/Deuterium Oxide, http://linkedlifedata.com/resource/pubmed/chemical/Enzyme Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Fucose, http://linkedlifedata.com/resource/pubmed/chemical/Fucosyltransferases, http://linkedlifedata.com/resource/pubmed/chemical/Guanosine Diphosphate, http://linkedlifedata.com/resource/pubmed/chemical/Guanosine Diphosphate Fucose, http://linkedlifedata.com/resource/pubmed/chemical/Imino Pyranoses, http://linkedlifedata.com/resource/pubmed/chemical/N-acetyllactosamine, http://linkedlifedata.com/resource/pubmed/chemical/Nucleotides, http://linkedlifedata.com/resource/pubmed/chemical/Oligosaccharides, http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Sugar Alcohols, http://linkedlifedata.com/resource/pubmed/chemical/deoxyfuconojirimycin, http://linkedlifedata.com/resource/pubmed/chemical/galactoside 3-fucosyltransferase
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
0006-2960
pubmed:author
pubmed:issnType
Print
pubmed:day
27
pubmed:volume
35
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
11183-95
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed-meshheading:8780523-1-Deoxynojirimycin, pubmed-meshheading:8780523-Amino Sugars, pubmed-meshheading:8780523-Antigens, CD15, pubmed-meshheading:8780523-Carbohydrate Sequence, pubmed-meshheading:8780523-Cations, Divalent, pubmed-meshheading:8780523-Deuterium Oxide, pubmed-meshheading:8780523-Enzyme Inhibitors, pubmed-meshheading:8780523-Fucose, pubmed-meshheading:8780523-Fucosyltransferases, pubmed-meshheading:8780523-Guanosine Diphosphate, pubmed-meshheading:8780523-Guanosine Diphosphate Fucose, pubmed-meshheading:8780523-Humans, pubmed-meshheading:8780523-Hydrogen-Ion Concentration, pubmed-meshheading:8780523-Imino Pyranoses, pubmed-meshheading:8780523-Kinetics, pubmed-meshheading:8780523-Magnetic Resonance Spectroscopy, pubmed-meshheading:8780523-Molecular Sequence Data, pubmed-meshheading:8780523-Nucleotides, pubmed-meshheading:8780523-Oligosaccharides, pubmed-meshheading:8780523-Recombinant Proteins, pubmed-meshheading:8780523-Substrate Specificity, pubmed-meshheading:8780523-Sugar Alcohols
pubmed:year
1996
pubmed:articleTitle
Mechanism and specificity of human alpha-1,3-fucosyltransferase V.
pubmed:affiliation
Department of Chemistry, Scripps Research Institute, La Jolla, California 92037, USA.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't